Publications

The Long-Term Safety and Efficacy of Vestronidase Alfa, Rhgus Enzyme Replacement Therapy, in Subjects with Mucopolysaccharidosis Vii (Vol 129, Pg 219, 2020)

AuthID
P-00T-BEK

Author(s)

Wang, RY

Franco, JFD

Lopez Valdez, J

Martins, E

Sutton, VR

Whitley, CB

Zhang, L

Cimms, T

Marsden, D

Jurecka, A

Harmatz, P

Document Type

Correction

Year published

2020

Published

in MOLECULAR GENETICS AND METABOLISM, ISSN: 1096-7192

Volume: 131, Issue: 1-2, Pages: 285-285 (1)

Indexing

Wos^®

Crossref^®

Google Scholar^®

Publication Identifiers

DOI: 10.1016/j.ymgme.2020.08.001

Wos: WOS:000600626600033

Source Identifiers

ISSN: 1096-7192

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

The Long-Term Safety and Efficacy of Vestronidase Alfa, Rhgus Enzyme Replacement Therapy, in Subjects with Mucopolysaccharidosis Vii (Vol 129, Pg 219, 2020)

Useful Links

Get Help

Federated Authentication (Click on the image)

The Long-Term Safety and Efficacy of Vestronidase Alfa, Rhgus Enzyme Replacement Therapy, in Subjects with Mucopolysaccharidosis Vii (Vol 129, Pg 219, 2020)

Useful Links

Get Help